Visual Prognosis in Giant Cell Arteritis

Jennings, 1938, Arteritis of the temporal vessels, Lancet, 1, 424, 10.1016/S0140-6736(00)86182-6 Wagener, 1958, The ocular lesions of temporal arteritis, Am J Ophthalmol, 45, 617, 10.1016/0002-9394(58)92165-2 Bruce, 1950, Temporal arteritis as a cause of blindness. Review of the literature and report of a case, Am J Ophthalmol, 33, 1568, 10.1016/0002-9394(50)91218-9 Hollenhorst, 1960, Neurologic aspects of temporal arteritis, Neurology, 10, 490, 10.1212/WNL.10.5.490 Bengtsson, 1982, Giant cell arteritis, Acta Med Scand Suppl, 658 Fernandez-Herlihy, 1988, Temporal arteritis: clinical aids to diagnosis, J Rheumatol, 15, 1797 Hugod, 1979, Temporal arteritis-progressive affection of vision during high-level corticosteroid therapy. A case report, Acta Med Scand, 205, 445, 10.1111/j.0954-6820.1979.tb06080.x Calamia, 1980, Clinical manifestations of giant cell (temporal) arteritis, Clin Rheumatic Dis, 6, 389, 10.1016/S0307-742X(21)00303-9 Faarvang, 1989, Giant cell arteritis: loss of vision during corticosteroid therapy, J Intern Med, 225, 215, 10.1111/j.1365-2796.1989.tb00066.x Cullen, 1972, Temporal arteritis. Occurrence of ocular complications 7 years after diagnosis, Br J Ophthalmol, 56, 584, 10.1136/bjo.56.8.584 Model, 1978, Reversal of blindness in temporal arteritis with methylprednisolone [letter], Lancet, 1, 340, 10.1016/S0140-6736(78)90126-5 Lipton, 1985, Gradual loss and recovery of vision in temporal arteritis, Arch Intern Med, 145, 2252, 10.1001/archinte.1985.00360120124023 Rosenfeld, 1986, Treatment of temporal arteritis with ocular involvement, Am J Med, 80, 143, 10.1016/0002-9343(86)90066-5 Diamond, 1991, Treatable blindness in temporal arteritis, Br J Ophthalmol, 75, 432, 10.1136/bjo.75.7.432 Matzkin, 1992, Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis, Ophthalmology, 99, 68, 10.1016/S0161-6420(92)32009-3 Hunder, 1990, The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum, 33, 1122, 10.1002/art.1780330810 Hunder, 1975, Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study, Ann Intern Med, 82, 613, 10.7326/0003-4819-82-5-613 Jones, 1981, Prognosis and management of polymyalgia rheumatica, Ann Rheum Dis, 40, 1, 10.1136/ard.40.1.1 Delecoeuillerie, 1988, Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients), Ann Rheum Dis, 47, 733, 10.1136/ard.47.9.733 Healey, 1977, Manifestations of giant cell arteritis, Med Clin North Am, 61, 261, 10.1016/S0025-7125(16)31331-1 Kyle, 1989, Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months, Ann Rheum Dis, 48, 658, 10.1136/ard.48.8.658 Whitfield, 1963, Temporal arteritis, Br J Ophthalmol, 47, 555, 10.1136/bjo.47.9.555 Herrick, 1980, Cranial arteritis. A preventable cause of blindness, Trans Ophthalmol Soc NZ, 32, 106 Bengtsson, 1982, Eye complications in giant cell arteritis, Acta Med Scand Suppl, 658, 38 Soelberg Sorensen, 1977, Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients, Acta Med Scand, 201, 207, 10.1111/j.0954-6820.1977.tb15683.x Huston, 1978, Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study, Ann Intern Med, 88, 162, 10.7326/0003-4819-88-2-162 Myles, 1992, Prevention of blindness in giant cell arteritis by corticosteroid treatment, Br J Rheumatol, 31, 103, 10.1093/rheumatology/31.2.103 Schneider, 1971, The visual prognosis in temporal arteritis, Ann Ophthalmol, 3, 1215